Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a respiratory illness with systemic immune cell activation, inflammation, widespread multiorgan dysfunction, and thrombosis.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) subvariant BA.2.86 was first reported in Denmark early in August 2023. 1 By August 30, a total of 24 cases had been detected in 8 ...

The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...

In summer 2025, the SARS-CoV-2 JN.1 sublineage became dominant with more resistant variants, such as XFG, LP.8.1, and NB.1.8.1. COVID-19 mRNA boosters were therefore updated for the 2025–2026 season ...

Interview with Ashish Jha on an investment by the Biden administration in the development of next-generation vaccines and treatments for SARS-CoV-2. 9m 26s Download The development of safe and ...